CASI logo

CASI Pharmaceuticals (CASI) Net Income

Annual Net Income

-$26.94 M
+$14.08 M+34.32%

December 31, 2023


Summary


Performance

CASI Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCASIprofitabilitymetrics:

Quarterly Net Income

-$8.39 M
-$1.43 M-20.53%

September 1, 2024


Summary


Performance

CASI Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCASIprofitabilitymetrics:

TTM Net Income

-$30.94 M
-$3.76 M-13.83%

September 1, 2024


Summary


Performance

CASI TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCASIprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CASI Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.3%-38.6%-14.9%
3 y3 years+44.2%-38.6%-14.9%
5 y5 years+1.9%-38.6%-14.9%

CASI Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+34.3%-81.1%+57.0%-14.9%+24.6%
5 y5-yearat high+44.2%-81.1%+57.0%-14.9%+42.4%
alltimeall time-490.9%+46.0%-236.2%+75.8%-1720.2%+49.7%

CASI Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$8.39 M(+20.5%)
-$30.94 M(+13.8%)
Jun 2024
-
-$6.96 M(-26.9%)
-$27.18 M(-10.7%)
Mar 2024
-
-$9.53 M(+57.4%)
-$30.46 M(+13.1%)
Dec 2023
-$26.94 M(-34.3%)
-$6.05 M(+30.6%)
-$26.94 M(-33.4%)
Sep 2023
-
-$4.63 M(-54.7%)
-$40.42 M(-1.4%)
Jun 2023
-
-$10.24 M(+70.4%)
-$40.99 M(+6.7%)
Mar 2023
-
-$6.01 M(-69.2%)
-$38.43 M(-6.3%)
Dec 2022
-$41.01 M(+11.9%)
-$19.54 M(+275.6%)
-$41.01 M(+51.5%)
Sep 2022
-
-$5.20 M(-32.3%)
-$27.08 M(-15.6%)
Jun 2022
-
-$7.68 M(-10.7%)
-$32.10 M(+2.3%)
Mar 2022
-
-$8.60 M(+53.5%)
-$31.37 M(-14.4%)
Dec 2021
-$36.65 M(-24.1%)
-$5.60 M(-45.2%)
-$36.65 M(-19.0%)
Sep 2021
-
-$10.22 M(+47.2%)
-$45.25 M(-12.9%)
Jun 2021
-
-$6.95 M(-50.0%)
-$51.98 M(-3.3%)
Mar 2021
-
-$13.88 M(-2.2%)
-$53.73 M(+11.3%)
Dec 2020
-$48.29 M(+4.9%)
-$14.20 M(-16.2%)
-$48.29 M(+3.7%)
Sep 2020
-
-$16.95 M(+95.0%)
-$46.58 M(+17.9%)
Jun 2020
-
-$8.69 M(+3.0%)
-$39.52 M(-14.6%)
Mar 2020
-
-$8.44 M(-32.4%)
-$46.30 M(+0.6%)
Dec 2019
-$46.03 M(+67.6%)
-$12.49 M(+26.3%)
-$46.03 M(+7.5%)
Sep 2019
-
-$9.89 M(-36.1%)
-$42.80 M(+2.7%)
Jun 2019
-
-$15.47 M(+89.2%)
-$41.67 M(+30.0%)
Mar 2019
-
-$8.18 M(-11.7%)
-$32.06 M(+16.7%)
Dec 2018
-$27.47 M(+155.1%)
-$9.26 M(+5.8%)
-$27.47 M(+18.1%)
Sep 2018
-
-$8.76 M(+49.4%)
-$23.25 M(+44.3%)
Jun 2018
-
-$5.86 M(+63.2%)
-$16.11 M(+27.3%)
Mar 2018
-
-$3.59 M(-28.9%)
-$12.66 M(+17.6%)
Dec 2017
-$10.77 M(+13.9%)
-$5.05 M(+212.9%)
-$10.77 M(+28.3%)
Sep 2017
-
-$1.61 M(-33.0%)
-$8.40 M(-0.9%)
Jun 2017
-
-$2.41 M(+41.7%)
-$8.48 M(-9.4%)
Mar 2017
-
-$1.70 M(-36.4%)
-$9.36 M(-1.0%)
Dec 2016
-$9.45 M(+31.2%)
-$2.67 M(+57.9%)
-$9.45 M(+11.4%)
Sep 2016
-
-$1.69 M(-48.6%)
-$8.48 M(+1.1%)
Jun 2016
-
-$3.29 M(+83.5%)
-$8.39 M(+16.6%)
Mar 2016
-
-$1.79 M(+5.4%)
-$7.20 M(-0.1%)
Dec 2015
-$7.21 M(-72.5%)
-$1.70 M(+6.1%)
-$7.21 M(+1.5%)
Sep 2015
-
-$1.60 M(-23.4%)
-$7.10 M(-73.7%)
Jun 2015
-
-$2.10 M(+16.2%)
-$27.03 M(+1.8%)
Mar 2015
-
-$1.80 M(+12.9%)
-$26.55 M(+1.3%)
Dec 2014
-$26.20 M(+356.6%)
-$1.60 M(-92.6%)
-$26.20 M(+1.1%)
Sep 2014
-
-$21.54 M(+1232.6%)
-$25.91 M(+345.4%)
Jun 2014
-
-$1.62 M(+11.4%)
-$5.82 M(-3.9%)
Mar 2014
-
-$1.45 M(+10.9%)
-$6.05 M(+5.5%)
Dec 2013
-$5.74 M(-60.5%)
-$1.31 M(-9.3%)
-$5.74 M(+19.8%)
Sep 2013
-
-$1.44 M(-22.1%)
-$4.79 M(+5.6%)
Jun 2013
-
-$1.85 M(+63.0%)
-$4.54 M(-65.5%)
Mar 2013
-
-$1.14 M(+215.2%)
-$13.15 M(-9.6%)
Dec 2012
-$14.55 M(+219.1%)
-$360.40 K(-69.7%)
-$14.55 M(+10.4%)
Sep 2012
-
-$1.19 M(-88.6%)
-$13.18 M(-0.9%)
Jun 2012
-
-$10.46 M(+312.9%)
-$13.30 M(+195.8%)
Mar 2012
-
-$2.53 M(-352.3%)
-$4.50 M(-1.4%)
Dec 2011
-$4.56 M(-43.7%)
$1.00 M(-176.8%)
-$4.56 M(+1.3%)
Sep 2011
-
-$1.31 M(-21.1%)
-$4.50 M(-14.9%)
Jun 2011
-
-$1.66 M(-36.1%)
-$5.29 M(-38.3%)
Mar 2011
-
-$2.60 M(-343.8%)
-$8.57 M(+5.8%)
Dec 2010
-$8.10 M
$1.06 M(-150.8%)
-$8.10 M(-25.7%)
Sep 2010
-
-$2.10 M(-57.6%)
-$10.90 M(+25.0%)
DateAnnualQuarterlyTTM
Jun 2010
-
-$4.94 M(+132.6%)
-$8.72 M(+27.7%)
Mar 2010
-
-$2.13 M(+22.7%)
-$6.83 M(-16.9%)
Dec 2009
-$8.22 M(-65.6%)
-$1.73 M(-2141.6%)
-$8.22 M(-9.0%)
Sep 2009
-
$84.90 K(-102.8%)
-$9.03 M(-27.8%)
Jun 2009
-
-$3.05 M(-13.2%)
-$12.51 M(-34.3%)
Mar 2009
-
-$3.52 M(+38.0%)
-$19.03 M(-20.2%)
Dec 2008
-$23.86 M(+6.5%)
-$2.55 M(-25.0%)
-$23.86 M(-4.9%)
Sep 2008
-
-$3.40 M(-64.5%)
-$25.08 M(+1.5%)
Jun 2008
-
-$9.57 M(+14.7%)
-$24.72 M(+7.1%)
Mar 2008
-
-$8.35 M(+121.5%)
-$23.08 M(+3.0%)
Dec 2007
-$22.41 M(-55.1%)
-$3.77 M(+24.1%)
-$22.41 M(-7.7%)
Sep 2007
-
-$3.04 M(-61.7%)
-$24.27 M(-2.0%)
Jun 2007
-
-$7.93 M(+3.4%)
-$24.76 M(+8.4%)
Mar 2007
-
-$7.67 M(+36.4%)
-$22.85 M(-54.2%)
Dec 2006
-$49.89 M(+205.8%)
-$5.63 M(+59.6%)
-$49.89 M(+7.4%)
Sep 2006
-
-$3.52 M(-41.5%)
-$46.44 M(-1.8%)
Jun 2006
-
-$6.03 M(-82.6%)
-$47.29 M(+3.8%)
Mar 2006
-
-$34.71 M(+1494.6%)
-$45.57 M(+179.3%)
Dec 2005
-$16.31 M(+29.2%)
-$2.18 M(-50.3%)
-$16.31 M(+13.3%)
Sep 2005
-
-$4.38 M(+1.9%)
-$14.40 M(+9.4%)
Jun 2005
-
-$4.30 M(-21.2%)
-$13.16 M(+0.4%)
Mar 2005
-
-$5.46 M(+1998.7%)
-$13.11 M(+3.9%)
Dec 2004
-$12.62 M(-35.3%)
-$260.00 K(-91.7%)
-$12.62 M(-31.1%)
Sep 2004
-
-$3.15 M(-25.9%)
-$18.31 M(-7.3%)
Jun 2004
-
-$4.25 M(-14.5%)
-$19.76 M(-4.9%)
Mar 2004
-
-$4.97 M(-16.5%)
-$20.77 M(+6.5%)
Dec 2003
-$19.49 M(-50.0%)
-$5.95 M(+29.4%)
-$19.49 M(+29.5%)
Sep 2003
-
-$4.60 M(-12.6%)
-$15.05 M(-32.2%)
Jun 2003
-
-$5.26 M(+42.5%)
-$22.21 M(-21.3%)
Mar 2003
-
-$3.69 M(+145.2%)
-$28.20 M(-27.7%)
Dec 2002
-$39.02 M(-9.9%)
-$1.50 M(-87.2%)
-$39.02 M(-36.6%)
Sep 2002
-
-$11.75 M(+4.4%)
-$61.52 M(+41.1%)
Jun 2002
-
-$11.25 M(-22.5%)
-$43.60 M(-7.7%)
Mar 2002
-
-$14.51 M(-39.5%)
-$47.23 M(+9.1%)
Dec 2001
-$43.31 M(-11.2%)
-$24.00 M(-489.3%)
-$43.31 M(+31.1%)
Sep 2001
-
$6.17 M(-141.4%)
-$33.04 M(-34.6%)
Jun 2001
-
-$14.88 M(+40.4%)
-$50.49 M(+3.6%)
Mar 2001
-
-$10.59 M(-22.9%)
-$48.75 M(-0.1%)
Dec 2000
-$48.79 M(+32.2%)
-$13.74 M(+21.8%)
-$48.79 M(-2.1%)
Sep 2000
-
-$11.28 M(-14.1%)
-$49.86 M(+9.6%)
Jun 2000
-
-$13.13 M(+23.4%)
-$45.48 M(+12.7%)
Mar 2000
-
-$10.64 M(-28.1%)
-$40.35 M(+9.5%)
Dec 1999
-$36.90 M(+173.3%)
-$14.80 M(+114.5%)
-$36.86 M(+38.3%)
Sep 1999
-
-$6.90 M(-13.8%)
-$26.66 M(+12.2%)
Jun 1999
-
-$8.01 M(+12.0%)
-$23.76 M(+35.4%)
Mar 1999
-
-$7.15 M(+55.4%)
-$17.55 M(+30.0%)
Dec 1998
-$13.50 M(+107.7%)
-$4.60 M(+15.0%)
-$13.50 M(+22.7%)
Sep 1998
-
-$4.00 M(+122.2%)
-$11.00 M(+25.0%)
Jun 1998
-
-$1.80 M(-41.9%)
-$8.80 M(+7.3%)
Mar 1998
-
-$3.10 M(+47.6%)
-$8.20 M(+26.2%)
Dec 1997
-$6.50 M(+35.4%)
-$2.10 M(+16.7%)
-$6.50 M(+14.0%)
Sep 1997
-
-$1.80 M(+50.0%)
-$5.70 M(+7.5%)
Jun 1997
-
-$1.20 M(-14.3%)
-$5.30 M(+15.2%)
Mar 1997
-
-$1.40 M(+7.7%)
-$4.60 M(-6.1%)
Dec 1996
-$4.80 M
-$1.30 M(-7.1%)
-$4.90 M(+36.1%)
Sep 1996
-
-$1.40 M(+180.0%)
-$3.60 M(+63.6%)
Jun 1996
-
-$500.00 K(-70.6%)
-$2.20 M(+29.4%)
Mar 1996
-
-$1.70 M
-$1.70 M

FAQ

  • What is CASI Pharmaceuticals annual net profit?
  • What is the all time high annual net income for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual net income year-on-year change?
  • What is CASI Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals quarterly net income year-on-year change?
  • What is CASI Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals TTM net income year-on-year change?

What is CASI Pharmaceuticals annual net profit?

The current annual net income of CASI is -$26.94 M

What is the all time high annual net income for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual net profit is -$4.56 M

What is CASI Pharmaceuticals annual net income year-on-year change?

Over the past year, CASI annual net profit has changed by +$14.08 M (+34.32%)

What is CASI Pharmaceuticals quarterly net profit?

The current quarterly net income of CASI is -$8.39 M

What is the all time high quarterly net income for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly net profit is $6.17 M

What is CASI Pharmaceuticals quarterly net income year-on-year change?

Over the past year, CASI quarterly net profit has changed by -$2.34 M (-38.65%)

What is CASI Pharmaceuticals TTM net profit?

The current TTM net income of CASI is -$30.94 M

What is the all time high TTM net income for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high TTM net profit is -$1.70 M

What is CASI Pharmaceuticals TTM net income year-on-year change?

Over the past year, CASI TTM net profit has changed by -$4.00 M (-14.87%)